keyword
https://read.qxmd.com/read/38534003/low-acuity-pediatric-emergency-department-utilization-caregiver-motivations
#1
JOURNAL ARTICLE
Lisa Ziemnik, Noah Parker, Kyra Bufi, Kristen Waters, Jacob Almeda, Adrienne Stolfi
OBJECTIVES: Proper emergency department (ED) utilization is a hallmark of population health. Emergency department overcrowding due to nonurgent visits causes increased stress to healthcare staff, higher costs, and longer wait times for more urgent cases. This study sought to better understand post pandemic reasons caregivers have when bringing in their children for nonurgent visits and devise effective interventions to improve caregiver choice for non-ED care for nonurgent conditions...
March 27, 2024: Pediatric Emergency Care
https://read.qxmd.com/read/37767836/-an-unexpected-case-of-right-heart-dilation-in-the-elderly
#2
JOURNAL ARTICLE
Michele Pagliaccia, Serenella Conti, Alessandro Bufi, Valentino Borghetti, Marcella De Paolis, Marcello Dominici
Atrial septal defects (ASD) represent the most common congenital heart defect diagnosed in adulthood. Adults with an ASD are often asymptomatic, but sometimes may present with non-specific symptoms such as dyspnea on exertion or exercise intolerance. Isolated sinus venosus atrial defect is an extremely rare anomaly. Sinus venosus defects occur more commonly in the superior (rather than inferior) portion of the embryologic sinus venosus and commonly occur with partial anomalous pulmonary venous return, particularly of the right upper pulmonary vein...
October 2023: Giornale Italiano di Cardiologia
https://read.qxmd.com/read/37046791/image-guided-localization-techniques-for-metastatic-axillary-lymph-nodes-in-breast-cancer-what-radiologists-should-know
#3
REVIEW
Valerio Di Paola, Giorgio Mazzotta, Marco Conti, Simone Palma, Federico Orsini, Laura Mola, Francesca Ferrara, Valentina Longo, Enida Bufi, Anna D'Angelo, Camilla Panico, Paola Clauser, Paolo Belli, Riccardo Manfredi
Targeted axillary dissection (TAD) is an axillary staging technique after NACT that involves the removal of biopsy-proven metastatic lymph nodes in addition to sentinel lymph node biopsy (SLNB). This technique avoids the morbidity of traditional axillary lymph node dissection and has shown a lower false-negative rate than SLNB alone. Therefore, marking positive axillary lymph nodes before NACT is critical in order to locate and remove them in the subsequent surgery. Current localization methods include clip placement with intraoperative ultrasound, carbon-suspension liquids, localization wires, radioactive tracer-based localizers, magnetic seeds, radar reflectors, and radiofrequency identification devices...
April 3, 2023: Cancers
https://read.qxmd.com/read/37046707/selective-axillary-dissection-after-neoadjuvant-chemotherapy-in-patients-with-lymph-node-positive-breast-cancer-clyp-study-the-radio-guided-occult-lesion-localization-technique-for-biopsy-proven-metastatic-lymph-nodes
#4
JOURNAL ARTICLE
Rossella Rella, Marco Conti, Enida Bufi, Charlotte Marguerite Lucille Trombadori, Alba Di Leone, Daniela Terribile, Riccardo Masetti, Luca Zagaria, Antonino Mulè, Francesca Morciano, Gianluca Franceschini, Paolo Belli
(1) Background: To help to refine the accuracy of sentinel lymph node biopsy (SLNB) in breast cancer (BC) patients with biopsy-proven nodal disease prior to neoadjuvant chemotherapy (NACT), a method of marking the biopsy-proven positive LN at diagnosis to enable its removal during surgery was proposed. The aim of this study was to evaluate the accuracy of the Radio-Guided Occult Lesion Localization (ROLL) technique of biopsy-proven metastatic LN in nodal staging after NACT among node-positive BC patients. (2) Methods: Patients with invasive BC and biopsy-proven axillary metastases receiving NACT were enrolled...
March 29, 2023: Cancers
https://read.qxmd.com/read/36900231/surgical-planning-after-neoadjuvant-treatment-in-breast-cancer-a-multimodality-imaging-based-approach-focused-on-mri
#5
REVIEW
Marco Conti, Francesca Morciano, Enida Bufi, Anna D'Angelo, Camilla Panico, Valerio Di Paola, Elisabetta Gori, Gianluca Russo, Giovanni Cimino, Simone Palma, Paolo Belli, Riccardo Manfredi
Neoadjuvant chemotherapy (NACT) today represents a cornerstone in the treatment of locally advanced breast cancer and highly chemo-sensitive tumors at early stages, increasing the possibilities of performing more conservative treatments and improving long term outcomes. Imaging has a fundamental role in the staging and prediction of the response to NACT, thus aiding surgical planning and avoiding overtreatment. In this review, we first examine and compare the role of conventional and advanced imaging techniques in preoperative T Staging after NACT and in the evaluation of lymph node involvement...
February 24, 2023: Cancers
https://read.qxmd.com/read/36497265/staging-breast-cancer-with-mri-the-t-a-key-role-in-the-neoadjuvant-setting
#6
REVIEW
Camilla Panico, Francesca Ferrara, Ramona Woitek, Anna D'Angelo, Valerio Di Paola, Enida Bufi, Marco Conti, Simone Palma, Stefano Lo Cicero, Giovanni Cimino, Paolo Belli, Riccardo Manfredi
Breast cancer (BC) is the most common cancer among women worldwide. Neoadjuvant chemotherapy (NACT) indications have expanded from inoperable locally advanced to early-stage breast cancer. Achieving a pathological complete response (pCR) has been proven to be an excellent prognostic marker leading to better disease-free survival (DFS) and overall survival (OS). Although diagnostic accuracy of MRI has been shown repeatedly to be superior to conventional methods in assessing the extent of breast disease there are still controversies regarding the indication of MRI in this setting...
November 24, 2022: Cancers
https://read.qxmd.com/read/36436181/peptide-based-ldh5-inhibitors-enter-cancer-cells-and-impair-proliferation
#7
JOURNAL ARTICLE
Ferran Nadal-Bufí, Lai Y Chan, Hadi H Mohammad, Jody M Mason, Carlos Salomon, Andrew Lai, Erik W Thompson, David J Craik, Quentin Kaas, Sónia T Henriques
Lactate dehydrogenase 5 (LDH5) is overexpressed in many cancers and is a potential target for anticancer therapy due to its role in aerobic glycolysis. Small-molecule drugs have been developed as competitive inhibitors to bind substrate/cofactor sites of LDH5, but none reached the clinic to date. Recently, we designed the first LDH5 non-competitive inhibitor, cGmC9, a peptide that inhibits protein-protein interactions required for LDH5 enzymatic activity. Peptides are gaining a large interest as anticancer agents to modulate intracellular protein-protein interactions not targetable by small molecules; however, delivery of these peptides to the cytosol, where LDH5 and other anticancer targets are located, remains a challenge for this class of therapeutics...
November 27, 2022: Cellular and Molecular Life Sciences: CMLS
https://read.qxmd.com/read/36077805/beyond-n-staging-in-breast-cancer-importance-of-mri-and-ultrasound-based-imaging
#8
REVIEW
Valerio Di Paola, Giorgio Mazzotta, Vincenza Pignatelli, Enida Bufi, Anna D'Angelo, Marco Conti, Camilla Panico, Vincenzo Fiorentino, Francesco Pierconti, Fleur Kilburn-Toppin, Paolo Belli, Riccardo Manfredi
The correct N-staging in breast cancer is crucial to tailor treatment and stratify the prognosis. N-staging is based on the number and the localization of suspicious regional nodes on physical examination and/or imaging. Since clinical examination of the axillary cavity is associated with a high false negative rate, imaging modalities play a central role. In the presence of a T1 or T2 tumor and 0-2 suspicious nodes, on imaging at the axillary level I or II, a patient should undergo sentinel lymph node biopsy (SLNB), whereas in the presence of three or more suspicious nodes at the axillary level I or II confirmed by biopsy, they should undergo axillary lymph node dissection (ALND) or neoadjuvant chemotherapy according to a multidisciplinary approach, as well as in the case of internal mammary, supraclavicular, or level III axillary involved lymph nodes...
August 31, 2022: Cancers
https://read.qxmd.com/read/35877642/multiple-papillomas-of-the-breast-a-review-of-current-evidence-and-challenges
#9
REVIEW
Rossella Rella, Giovanna Romanucci, Damiano Arciuolo, Assunta Scaldaferri, Enida Bufi, Sebastiano Croce, Andrea Caulo, Oscar Tommasini
OBJECTIVES: To conduct a review of evidence about papillomatosis/multiple papillomas (MP), its clinical and imaging presentation, the association between MP and malignancy and the management strategies that follow. METHODS: A computerized literature search using PubMed and Google Scholar was performed up to January 2021 with the following search strategy: "papilloma" OR "intraductal papilloma" OR "intraductal papillary neoplasms" OR "papillomatosis" OR "papillary lesion" AND "breast"...
July 13, 2022: Journal of Imaging
https://read.qxmd.com/read/35585020/association-between-contralateral-background-parenchymal-enhancement-on-mri-and-outcome-in-patients-with-unilateral-invasive-breast-cancer-breast-receiving-neoadjuvant-chemotherapy
#10
JOURNAL ARTICLE
Rossella Rella, Enida Bufi, Paolo Belli, Anna Rita Scrofani, Federica Petta, Alberto Borghetti, Fabio Marazzi, Vincenzo Valentini, Riccardo Manfredi
PURPOSE: The purpose of this study was to retrospectively investigate whether background parenchymal enhancement (BPE) of the contralateral breast on magnetic resonance imaging (MRI) is associated with clinical outcomes in patients with unilateral invasive breast cancer receiving neoadjuvant chemotherapy (NAC). MATERIALS AND METHODS: A total of 228 women (47.6 years ± 10 [SD]; range: 24-74 years) with invasive breast cancer who underwent NAC between 2005 and 2013 were included...
May 15, 2022: Diagnostic and Interventional Imaging
https://read.qxmd.com/read/35429495/the-impact-of-genetic-background-on-mouse-models-of-kidney-disease
#11
REVIEW
Rei Bufi, Ron Korstanje
The mouse is the most commonly used mammalian model to study disease, including kidney disease. However, close attention needs to be paid to the differences and effects of genetic background. The default choice of most investigators is to use C57BL/6 mice, but not all C57BL/6 mice are the same. Ever since the C57BL/6 line was first established, differences in the genetic background have risen between substrains, which have major implications in the phenotypes expressed in kidney disease. Furthermore, considering that C57BL/6 substrains are relatively resistant to kidney damage, there can be major benefits in selecting other mouse inbred strains when studying kidney disease...
July 2022: Kidney International
https://read.qxmd.com/read/34754833/osteolysis-in-total-hip-arthroplasty-in-relation-to-metal-ion-release-comparison-between-monolithic-prostheses-and-different-modularities
#12
JOURNAL ARTICLE
Francesco Manfreda, Egzon Bufi, Enrico Francesco Florio, Paolo Ceccarini, Giuseppe Rinonapoli, Auro Caraffa, Pierluigi Antinolfi
BACKGROUND: Among the various complications associated with total hip arthroplasty (THA) periprosthetic osteolysis and wear phenomena due to the release of metal particles, are two of the most common and have been reported to be correlated because of inflammatory responses directed towards released particles that generally activate macrophagic osteolytic effects. Therein, new masses known as pseudotumors can appear in soft tissues around a prosthetic implant. To date, there is paucity of reliable data from studies investigating for any association between the above mentioned adverse events...
October 18, 2021: World Journal of Orthopedics
https://read.qxmd.com/read/34191930/breast-adjuvant-radiotherapy-amid-the-covid-19-crisis-in-a-hub-cancer-center-lombardy-italy
#13
JOURNAL ARTICLE
Maria Cristina Leonardi, Emilia Montagna, Viviana Enrica Galimberti, Mattia Zaffaroni, Damaris Patricia Rojas, Samantha Dicuonzo, Maria Alessia Zerella, Anna Morra, Claudia Sangalli, Sara Gandini, Marco Colleoni, Paolo Veronesi, Marianna Alessandra Gerardi, Daniela Alterio, Roberta Lazzari, Massimo Sarra Fiore, Giammaria Bufi, Federica Cattani, Fabrizio Mastrilli, Roberto Orecchia, Barbara Alicja Jereczek-Fossa
Introduction: During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Methods: Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed...
December 16, 2020: Breast Care
https://read.qxmd.com/read/33765386/designed-%C3%AE-hairpins-inhibit-ldh5-oligomerization-and-enzymatic-activity
#14
JOURNAL ARTICLE
Ferran Nadal-Bufi, Jody M Mason, Lai Yue Chan, David J Craik, Quentin Kaas, Sónia Troeira Henriques
Lactate dehydrogenase 5 (LDH5) is overexpressed in metastatic tumors and is an attractive target for anticancer therapy. Small-molecule drugs have been developed to target the substrate/cofactor sites of LDH5, but none has reached the clinic to date, and alternative strategies remain almost unexplored. Combining rational and computer-based approaches, we identified peptidic sequences with high affinity toward a β-sheet region that is involved in protein-protein interactions (PPIs) required for the activity of LDH5...
March 25, 2021: Journal of Medicinal Chemistry
https://read.qxmd.com/read/33577020/is-subareolar-intraoperative-biopsy-still-necessary-to-predict-nipple-involvement
#15
JOURNAL ARTICLE
E Bufi, M Piacentini, P Belli, M Conti, G Ciriello, G Franceschini, M Giuliani, D Terribile, I Valente, R Manfredi
OBJECTIVE: To predict the occult tumor involvement of nipple-areola complex (NAC) using preoperative MR imaging and to investigate whether the intraoperative histopathological examination of the subareolar tissue is still necessary. PATIENTS AND METHODS: Out of 712 patients submitted to nipple-sparing mastectomy (NSM) between 2014 and 2019, we selected 188 patients who underwent preoperative breast MRI. Breast MRI and intraoperative histopathological examination of the subareolar tissue were performed to predict NAC involvement at permanent pathology...
January 2021: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/33385300/automated-breast-volume-scanner-abvs-compared-to-handheld-ultrasound-hhus-and-contrast-enhanced-magnetic-resonance-imaging-ce-mri-in-the-early-assessment-of-breast-cancer-during-neoadjuvant-chemotherapy-an-emerging-role-to-monitoring-tumor-response
#16
COMPARATIVE STUDY
Anna D'Angelo, Armando Orlandi, Enida Bufi, Sara Mercogliano, Paolo Belli, Riccardo Manfredi
OBJECTIVES: To investigate the role of automated breast volume scanner (ABVS) compared to handheld ultrasound (HHUS) and contrast-enhanced magnetic resonance imaging (CE-MRI) in the early detection of patients with locally advanced breast cancer who are more likely to reach a complete pathological response (pCR) during neoadjuvant chemotherapy (NAC). METHODS: A single-institution prospective study was performed in patients with histological diagnosis of invasive breast cancer, eligible for NAC, and who were to undergo surgery in our Hospital...
April 2021: La Radiologia Medica
https://read.qxmd.com/read/33327890/covid-19-impact-in-radiotherapy-practice-in-an-oncology-hub-a-screenshot-from-lombardy-italy
#17
JOURNAL ARTICLE
Giulia Corrao, Luca Bergamaschi, Mattia Zaffaroni, Massimo Sarra Fiore, Giammaria Bufi, Maria Cristina Leonardi, Roberta Lazzari, Daniela Alterio, Federica Cattani, Gabriella Pravettoni, Fabrizio Mastrilli, Roberto Orecchia, Giulia Marvaso, Barbara Alicja Jereczek-Fossa
OBJECTIVE: During 2020, medical clinical activities were dramatically modified by the coronavirus disease 2019 (COVID-19) emergency. We aim to evaluate the impact of COVID-19 on radiotherapy (RT) practice in a hub cancer center. METHODS: Retrospective data collection of patients with suspected COVID-19 infection, identified by pathognomonic symptoms feedback at triage realized at the entrance to RT division. Inclusion criteria were diagnosis of oncologic disease, COVID-19-related symptoms, and signed written informed consent...
December 16, 2020: Tumori
https://read.qxmd.com/read/33078909/clinical-characterization-of-glioblastoma-patients-living-longer-than-2-years-a-retrospective-analysis-of-two-italian-institutions
#18
JOURNAL ARTICLE
Paola Anselmo, Ernesto Maranzano, Adelina Selimi, Marco Lupattelli, Isabella Palumbo, Vittorio Bini, Michelina Casale, Fabio Trippa, Alessandro Bufi, Fabio Arcidiacono, Cynthia Aristei
AIM: Despite the advances in surgery and radio-chemotherapy, the prognosis of glioblastoma (GBM) remains poor with about 13% of patients alive at 24 months. METHODS: A total of 75 long-term survivors (LTS), defined as alive at least 24 months from diagnosis, were retrospectively analyzed. Overall survival (OS) and recurrence-free-survival (RFS) were calculated and related to patient characteristics and treatment received. RESULTS: Median age and Karnofsky performance status (KPS) were 56 years and 100%, respectively...
October 20, 2020: Asia-Pacific Journal of Clinical Oncology
https://read.qxmd.com/read/33035073/background-parenchymal-enhancement-and-breast-cancer-a-review-of-the-emerging-evidences-about-its-potential-use-as-imaging-biomarker
#19
JOURNAL ARTICLE
Rossella Rella, Andrea Contegiacomo, Enida Bufi, Sara Mercogliano, Paolo Belli, Riccardo Manfredi
OBJECTIVES: to conduct a systematic review of evidences about the relationship between background parenchymal enhancement (BPE) of the contralateral healthy breast and breast cancer: its association with clinicopathological breast cancer characteristics, its potential as predictive and prognostic biomarker and the biological linkage between BPE and breast cancer. METHODS: a computerized literature search using PubMed and Google Scholar was performed up to June 2020...
October 9, 2020: British Journal of Radiology
https://read.qxmd.com/read/32654985/association-between-background-parenchymal-enhancement-and-tumor-response-in-patients-with-breast-cancer-receiving-neoadjuvant-chemotherapy
#20
JOURNAL ARTICLE
R Rella, E Bufi, P Belli, F Petta, T Serra, V Masiello, A R Scrofani, R Barone, A Orlandi, V Valentini, R Manfredi
PURPOSE: To analyze the relationships between background parenchymal enhancement (BPE) of the contralateral healthy breast and tumor response after neoadjuvant chemotherapy (NAC) in women with breast cancer. MATERIALS AND METHODS: A total of 228 women (mean age, 47.6 years±10 [SD]; range: 24-74 years) with invasive breast cancer who underwent NAC were included. All patients underwent breast magnetic resonance imaging (MRI) before and after NAC and 127 patients underwent MRI before, during (after the 4th cycle of NAC) and after NAC...
July 9, 2020: Diagnostic and Interventional Imaging
keyword
keyword
164745
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.